Evidence map›Paper›PMID 30276534›Full record

ReviewPediatric nephrology (Berlin, Germany)2019

Towards adulthood with a solitary kidney.

Pierre Cochat, Olivia Febvey, Justine Bacchetta, Etienne Bérard, Natalia Cabrera, Laurence Dubourg

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric nephrology (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Salt sensitivity of blood pressure in childhood and adolescence.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Childhood risk factors for adulthood chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  17. Article
  18. Article
  19. Born with a solitary kidney: at risk of hypertension.Pediatric nephrology (Berlin, Germany) · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Pierre CochatCentre de référence des maladies rénales rares Néphrogones, Hospices Civils de Lyon, Lyon, France. pierre.cochat@chu-lyon.fr.ORCID 0000-0003-2131-858X
Olivia FebveyEPICIME Epidémiologie Pharmacologie Investigation Clinique Information Médicale de l'Enfant, Hospices Civils de Lyon, Lyon, France.
Justine BacchettaCentre de référence des maladies rénales rares Néphrogones, Hospices Civils de Lyon, Lyon, France.
Etienne BérardNéphrologie pédiatrique, CHU Lenval, Nice, France.
Natalia CabreraCentre de référence des maladies rénales rares Néphrogones, Hospices Civils de Lyon, Lyon, France.
Laurence DubourgCentre de référence des maladies rénales rares Néphrogones, Hospices Civils de Lyon, Lyon, France.
Université Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FRCentre Hospitalier Universitaire de Nice · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Around 1/1000 people have a solitary kidney. Congenital conditions mainly include multicystic dysplastic kidney and unilateral renal aplasia/agenesis; acquired conditions are secondary to nephrectomy performed because of urologic structural abnormalities, severe parenchymal infection, renal trauma, and renal or pararenal tumors. Children born with congenital solitary kidney have a better long-term glomerular filtration rate than those with solitary kidney secondary to nephrectomy later in life. Acute and chronic adaptation processes lead to hyperfiltration followed by fibrosis in the remnant kidney, with further risk of albuminuria, arterial hypertension, and impaired renal function. Protective measures rely on non-pharmacological renoprotection (controlled protein and sodium intake, avoidance/limitation of nephrotoxic agents, keeping normal body mass index, and limitation of tobacco exposure). Lifelong monitoring should include blood pressure and albuminuria assessment, completed by glomerular filtration rate (GFR) estimation in case of abnormal values. In the absence of additional risk factors to solitary kidney, such assessment can be proposed every 5 years. There is no current consensus for indication and timing of pharmacological intervention.

Indexed as

Adaptation, PhysiologicalAdultAnimalsChildClinical Trials as TopicDisease Models, AnimalGlomerular Filtration RateHumansHypertrophyKidneyKidney NeoplasmsNephrectomySolitary KidneyCKDHyperfiltrationNephron massRenal fibrosisSolitary kidney

Identifiers

PMID30276534
OpenAlexW2895183196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.